Atlas Trials

High-risk Diffuse Large B-cell Lymphoma

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch High-risk Diffuse Large B-cell Lymphoma

RecordFirmDate
Effect of Blinatumomab on Minimal Residual Disease (MRD) in Diffuse Large B-Cell Lymphoma (DLBCL) Subjects Post Autologous Hematopoietic Stem Cell Transplantation (aHSCT) (NCT03298412)Amgen2018-05-23
Safety and Efficacy of Blinatumomab in Adults With Newly Diagnosed High-risk Diffuse Large B-Cell Lymphoma (NCT03023878)Amgen2017-03-13

Track High-risk Diffuse Large B-cell Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.